Search research articles
Contact Us
Filters
Showing results (1-10 of 37) with videos related to
Page
of 4
Sort By:
Current Drug Targets
|
July 18, 2003
Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes
P Theuma, V A Fonseca
Metabolic Syndrome and Related Disorders
|
March 29, 2008
Inflammation, insulin resistance, and atherosclerosis
Pierre Theuma, V A Fonseca
Comprehensive Therapy
|
October 16, 1999
Recent advances in pharmacological treatment of type 2 diabetes mellitus
A A Parulkar, V A Fonseca
Southern Medical Journal
|
February 5, 1999
Insulin resistance syndrome: options for treatment
M C Granberry, V A Fonseca
American Family Physician
|
February 15, 1997
Recent advances in the treatment of type II diabetes mellitus
B S Baliga, V A Fonseca
The American Journal of the Medical Sciences
|
September 16, 1999
Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: response to octreotide
M Barhoum, L Hutchins, V A Fonseca
Diabetes Care
|
April 1, 1994
Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine
M N Munshi, R E Martin, V A Fonseca
Pharmacotherapy
|
October 3, 1998
The role of troglitazone in treating the insulin resistance syndrome
M C Granberry, E F Schneider, V A Fonseca
Postgraduate Medical Journal
|
October 1, 1987
Tetany despite normocalcaemia and normomagnesaemia following parathyroidectomy
V A Fonseca, R D Bloom, R Dick, et al.
Postgraduate Medical Journal
|
January 1, 1987
Insulinoma presenting as alcoholic stupor
P Dandona, V A Fonseca, D P Mikhailidis, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 37) with videos related to
Sort By:
Page
of 4
Current Drug Targets
|
July 18, 2003
Novel cardiovascular risk factors and macrovascular and microvascular complications of diabetes
P Theuma, V A Fonseca
Metabolic Syndrome and Related Disorders
|
March 29, 2008
Inflammation, insulin resistance, and atherosclerosis
Pierre Theuma, V A Fonseca
Comprehensive Therapy
|
October 16, 1999
Recent advances in pharmacological treatment of type 2 diabetes mellitus
A A Parulkar, V A Fonseca
Southern Medical Journal
|
February 5, 1999
Insulin resistance syndrome: options for treatment
M C Granberry, V A Fonseca
American Family Physician
|
February 15, 1997
Recent advances in the treatment of type II diabetes mellitus
B S Baliga, V A Fonseca
The American Journal of the Medical Sciences
|
September 16, 1999
Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: response to octreotide
M Barhoum, L Hutchins, V A Fonseca
Diabetes Care
|
April 1, 1994
Hyperosmolar nonketotic diabetic syndrome following treatment of human immunodeficiency virus infection with didanosine
M N Munshi, R E Martin, V A Fonseca
Pharmacotherapy
|
October 3, 1998
The role of troglitazone in treating the insulin resistance syndrome
M C Granberry, E F Schneider, V A Fonseca
Postgraduate Medical Journal
|
October 1, 1987
Tetany despite normocalcaemia and normomagnesaemia following parathyroidectomy
V A Fonseca, R D Bloom, R Dick, et al.
Postgraduate Medical Journal
|
January 1, 1987
Insulinoma presenting as alcoholic stupor
P Dandona, V A Fonseca, D P Mikhailidis, et al.
Page
of 4